StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Core SG&A by Quarter

Core SG&A ($M)

QuarterlyAnnual

Novartis Core SG&A: -$3,078M in Q3 2026, down 6.8% from a year earlier.

Latest, Q3 2026
-3,078
Period ended Sep 30, 2026
Change on a year earlier
-6.8%
-3,304 in Q3 2025
History
35 quarters
Since Q4 2017
Sources
30
Documents cited below

Where the Q3 2026 figure comes from

“|| Selling, general and administration | – 3 082 | 5 | – 1 | – 3 078 | – 3 304”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore SG&A ($M)Year on yearSource
Q3 2026Sep 30, 2026-3,078-6.8%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026-3,231-6.1%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-3,137+2.6%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-3,436-1.9%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025-3,304+5.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 2025-3,441+11.4%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 2025-3,057+7.6%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 2024-3,501–Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 2024-3,133+1.3%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 2024-3,090+0.1%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 2024-2,840-0.8%Novartis Form 6-K (0001370368-25-000010) ↗
Q3 2023Sep 30, 2023-3,093+5.6%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023-3,088+2,473.3%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 2023-2,864+2,457.1%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 2022-560-1.1%Novartis Form 6-K (0001370368-23-000008) ↗
Q3 2022Sep 30, 2022-2,929+2,118.9%Novartis Form 6-K (0001370368-23-000068) ↗

Cite this data

StockData. (2026). Novartis Core SG&A ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-sga

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.